COMMUNIQUÉS West-GlobeNewswire

Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND
26/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced five poster presentations at the 29 th International Symposium on ALS/MND in Glasgow, Scotland, UK. The [...]
VitalHub Continues to Report Positive Adjusted EBITDA Results and Increased Revenues
26/11/2018
TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]
Xbrane Biopharma presents nomination committee
26/11/2018
Press release 2018-11-26 In accordance with the principles of the nomination committee of Xbrane Biopharma AB (" Company " or " Xbrane "), adopted at the Annual General Meeting on 24 May 2018, the Nomination Committee [...]
Hair Today, Gone Tomorrow: Dermatologists Debunk Common Misconceptions About Laser Hair Removal; American Academy of Dermatology
26/11/2018
AAD warns consumers that laser hair removal can be dangerous in inexperienced hands ROSEMONT, Ill., Nov. 26, 2018 (GLOBE NEWSWIRE) -- When performed by a doctor, laser hair removal is a safe, effective and permanent [...]
iCAD Unveils ProFound AI™ for Digital Breast Tomosynthesis at RSNA 2018
26/11/2018
Clinical results presented demonstrate outstanding outcomes with world-class artificial intelligence NASHUA, N.H. and CHICAGO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- (Booth #3911 and #8161) – iCAD, Inc. (NASDAQ: ICAD), a [...]
Sanofi: Disclosure of trading in own shares
26/11/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
26/11/2018
Pièce jointe Reporting FR.pdf
OSE Immunotherapeutics Receives Belgian Authorization for a Phase 1 Clinical Trial to Evaluate Anti-IL-7 Receptor Antagonist OSE-127
26/11/2018
NANTES, France, Nov. 26, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) today announced authorization by Federal Agency for Medicines and Health Products (FAMH) and Belgian Ethics [...]
Opthea Confirms Final Patient Enrolment in Phase 2b Wet AMD Clinical Trial
26/11/2018
MELBOURNE, Australia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, is pleased to report that the last [...]
Vital® Celebrates 30 Years of Leadership at RSNA 2018
26/11/2018
A global leader in healthcare imaging, Vital is excited to share its latest innovations in enterprise imaging MINNETONKA, Minn., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Built on 30 years of innovation and leadership in [...]
Ossur Hf : Transactions in relation to share buyback program
26/11/2018
Announcement no. 68/2018 26 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Zealand Pharma announces change in Executive Management
26/11/2018
Company announcement – No. 29/2018 Zealand Pharma announces change in Executive Management Copenhagen, Denmark, November 26, 2018 – Zealand Pharma A/S announces that Britt Meelby Jensen has today delivered her notice to [...]
Emisphere Development Update
26/11/2018
ROSELAND, N.J., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Novo Nordisk announced the completion and results on Thursday, November 22 and Friday, November 23 regarding their Pioneer 9 and Pioneer 6 phase 3a trials, both [...]
CohBar Founder Dr. Nir Barzilai Awarded the 2018 Fondation IPSEN Longevity Prize
26/11/2018
Honored for his groundbreaking research on the determinants of longevity in human centenarians and associated models MENLO PARK, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage [...]
NRC Health Awards Annual Scholarship to UNL Students
26/11/2018
NRC Health awards Rising Stars Scholarship to successful business students and will recognize accomplishments at celebratory dinner LINCOLN, Neb., Nov. 26, 2018 (GLOBE NEWSWIRE) -- NRC Health is pleased to announce [...]
Valens GroWorks Focused on the (Near) Future of the Cannabis Industry -- CFN Media
26/11/2018
SEATTLE, Nov. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Advantis Corp Attended the MjBizCon in Las Vegas Last Week and Took the Opportunity to Network with Current and Future Clients and Partners
26/11/2018
NEWPORT BEACH, CA, Nov. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) attended the MjBizCon in Las Vegas last week and took the opportunity to network with current and future [...]
Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study
26/11/2018
Topline results for Phase III MicroStat program expected H1 2019 NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of [...]
Tetra Bio-Pharma’s Dr. Chamberland Goes to Washington!
26/11/2018
ORLEANS, Ontario, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to update the market that Dr. Guy [...]

Pages